Kenneth Frazier | |
|---|---|
 | |
| Born | Kenneth Carleton Frazier December 17, 1954 Philadelphia, Pennsylvania, U.S. |
| Education | Pennsylvania State University, University Park (BA) Harvard University (JD) |
| Occupation(s) | Executive chairman, Merck & Co. |
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies).[1] He was elected to the American Philosophical Society in 2018.[2]
Frazier was included in Time's list of the most influential people in the world in 2018 and 2021.[3][4]
- ^ Davis, Dominic-Madori. "There are only four black Fortune 500 CEOs. Here they are". Business Insider. Retrieved 2020-03-04.
- ^ "Election of New Members at the 2018 Spring Meeting".
- ^ Trinacria, Joe (April 19, 2018). "A Pair of Philadelphians Made Time's 100 Most Influential People List". Philadelphia. Retrieved November 13, 2021.
- ^ "Kenneth Frazier And Sherrilyn Ifill Among Time's Most Influential People of 2021". American Law Institute. September 21, 2021. Retrieved November 13, 2021.